Summit Global Investments »

Ptc Therapeutics I shares owned by Summit Global Investments

Quarter-by-quarter ownership of Ptc Therapeutics I (PTCT) shares owned by Summit Global Investments from 13F filings

Historical chart of Summit Global Investments investment in Ptc Therapeutics I

Tip: Access up to 7 years of quarterly data

All positions including Ptc Therapeutics I held by Summit Global Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ptc Therapeutics I by Summit Global Investments

Quarter filed Position value Share count Share price at filing
2025-12-31 $242k 3.2k 75.96

More positions owned by Summit Global Investments

RBB Sgi Enhanced Cor (USDX)
RBB Sgi Enhanced Mkt (LDRX)
RBB Sgi Us Large Cap (SGLC)
RBB Sgi Enhanced Glb (GINX)
RBB Sgi Diversi Tac (DYTA)
Ishares Tr Core Us Aggbd Et (AGG)
RBB Sgi Enhanced Nas (QXQ)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Spdr Index Shs Fds Portfolio Emg Mk (SPEM)
Tesla Motors (TSLA)
Microsoft Corporation (MSFT)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Summit Global Investments

Top funds holding Ptc Therapeutics I

BlackRock
Vanguard Group
Rtw Investments
Wellington Management Company
State Street Corporation
Henderson Group
Armistice Capital
Toronto-Dominion Bank
D. E. Shaw & Co
Geode Capital Management
Citadel Advisors
Leucadia National Corporation
FMR
Tang Capital Management
Franklin Resources

View all funds holding Ptc Therapeutics I